NPM1 and acute myeloid leukemia: Among the 83 patients with AML with NPM1, the subtypes were as follows: type A (most common), comprising 66/83 (79.5%); type B, comprising 13/83 (15.6%); and type D, comprising 4/83 (4.9%).